Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Distrutti

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Obesity Surgery|May 10, 2019
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related ComorbiditiesStefano De Vuono, Maria Anastasia Ricci, Elisa Nulli Migliola, et al.
Frontiers in Chemistry|November 16, 2020
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding DomainAdriana Carino, Federica Moraca, Bianca Fiorillo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 28, 2020
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagyAdriana Carino, Silvia Marchianò, Michele Biagioli, et al.
Frontiers in Oncology|July 18, 2022
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor PrognosisCristina Di Giorgio, Silvia Marchianò, Elisabetta Marino, et al.
Nutrients|May 24, 2019
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets FormationAdriana Carino, Silvia Marchianò, Michele Biagioli, et al.
Scientific Reports|January 28, 2023
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASHSilvia Marchianò, Michele Biagioli, Elva Morretta, et al.
Biochemical Pharmacology|April 25, 2020
Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1Michele Biagioli, Adriana Carino, Silvia Marchianò, et al.
Hepatology (Baltimore, Md.)|September 15, 2022
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injuryMichele Biagioli, Silvia Marchianò, Cristina di Giorgio, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 7, 2020
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasisAdriana Carino, Michele Biagioli, Silvia Marchianò, et al.
Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Obesity Surgery|May 10, 2019
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related ComorbiditiesStefano De Vuono, Maria Anastasia Ricci, Elisa Nulli Migliola, et al.
Frontiers in Chemistry|November 16, 2020
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding DomainAdriana Carino, Federica Moraca, Bianca Fiorillo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 28, 2020
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagyAdriana Carino, Silvia Marchianò, Michele Biagioli, et al.
Frontiers in Oncology|July 18, 2022
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor PrognosisCristina Di Giorgio, Silvia Marchianò, Elisabetta Marino, et al.
Nutrients|May 24, 2019
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets FormationAdriana Carino, Silvia Marchianò, Michele Biagioli, et al.
Scientific Reports|January 28, 2023
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASHSilvia Marchianò, Michele Biagioli, Elva Morretta, et al.
Biochemical Pharmacology|April 25, 2020
Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1Michele Biagioli, Adriana Carino, Silvia Marchianò, et al.
Hepatology (Baltimore, Md.)|September 15, 2022
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injuryMichele Biagioli, Silvia Marchianò, Cristina di Giorgio, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 7, 2020
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasisAdriana Carino, Michele Biagioli, Silvia Marchianò, et al.
Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.
Pageof 14